Thiel-backed psychedelics startup Atai valued at $3.19 billion in Nasdaq debut

·

·

Thiel-backed psychedelics startup Atai valued at $3.19 billion in Nasdaq debut

(Reuters) -Shares of Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, surged 40% in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion. FILE PHOTO: A view of the exterior of …
See Original Article

India's Paytm Plans $3 Billion IPO At Minimum $25 Billion Valuation

Indian payments platform Paytm is planning an initial public offering (IPO) with plans to raise $3 billion at an estimated $29 billion, a listing that is expected to be the biggest in the country, Financial Times (FT) reported, citing sources. Paytm, co-founded by its …
See Original Article

Blood drive: Milwaukee County Zoo offers perks if you donate

The American Red Cross is experiencing a severe blood shortage. Between trauma cases, organ transplants and elective surgeries, the nation’s blood inventory is running low. The good news is, in most cases people who have received the COVID-19 vaccine …
See Original Article

Indiana Accounting Firm Must Go to Trial on City Charges

LLC, an accounting and advisory firm based in Indianapolis. The city sued London Witte alleging negligence, breach of fiduciary duty, and constructive
See Original Article

Why Sykes Stock Skyrocketed on Friday

Sitel has agreed to buy all outstanding Sykes shares in an all-cash deal that values the latter company at $54 per share, representing a valuation of approximately $2.2 billion on a fully diluted basis. That price translates into a premium of 31% over yesterday’s …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.